PTC Therapeutics (PTCT) PT Lowered to $42 at RBC Capital
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $72.97 +1.77%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on PTC Therapeutics (NASDAQ: PTCT) to $42.00 (from $45.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- PTC Therapeutics (PTCT) PT Raised to $122 at Barclays
- Central Retail Corp PCL (CRC:TB) PT Lowered to THB9,000 at Macquarie
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
